Christopher B Wheelock, MD | |
2550 Mosside Blvd Ste 500, Monroeville, PA 15146-3514 | |
(412) 457-1100 | |
(412) 457-0250 |
Full Name | Christopher B Wheelock |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 20 Years |
Location | 2550 Mosside Blvd Ste 500, Monroeville, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073669891 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD475230 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Forbes Hospital | Monroeville, PA | Hospital |
Allegheny General Hospital | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allegheny Clinic | 5395649586 | 1941 |
News Archive
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Texas is ranked in the top quarter of the U.S. for its worksite lactation support initiatives, according to research led by The University of Texas Health Science Center at Houston School of Public Health.
The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 2 days ago
Entity Name | Allegheny Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Texas is ranked in the top quarter of the U.S. for its worksite lactation support initiatives, according to research led by The University of Texas Health Science Center at Houston School of Public Health.
The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher B Wheelock, MD 2550 Mosside Blvd Ste 500, Monroeville, PA 15146-3514 Ph: (412) 457-1100 | Christopher B Wheelock, MD 2550 Mosside Blvd Ste 500, Monroeville, PA 15146-3514 Ph: (412) 457-1100 |
News Archive
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Texas is ranked in the top quarter of the U.S. for its worksite lactation support initiatives, according to research led by The University of Texas Health Science Center at Houston School of Public Health.
The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 2 days ago
Ereny Refaat Gendy Eskarous, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4175 Ivanhoe Dr, Monroeville, PA 15146 Phone: 330-881-4940 | |
Dr. Leslie B Zuverink, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1620 Golden Mile Hwy Ste 100, Monroeville, PA 15146 Phone: 724-744-5151 Fax: 724-327-7221 | |
Manasa Manapragada Irwin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 Mosside Blvd Ste 500, Monroeville, PA 15146 Phone: 412-457-1100 Fax: 412-457-0250 | |
Dr. Fahd Anzaar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2566 Haymaker Rd, Monroeville, PA 15146 Phone: 412-858-2760 Fax: 412-858-4430 | |
Arthur Magno Santos, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 James Pl Ste 301, Monroeville, PA 15146 Phone: 724-612-0959 Fax: 412-998-7849 | |
Dr. Roslin Thongsri, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 Mosside Blvd, Suite 500, Monroeville, PA 15146 Phone: 412-457-1100 Fax: 412-457-0250 |